We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group (CME) Q1 Earnings Top Estimates, Revenues Rise Y/Y
Read MoreHide Full Article
CME Group Inc. (CME - Free Report) reported first-quarter 2024 adjusted earnings per share of $2.50, which beat the Zacks Consensus Estimate by 2.4%. The bottom line increased 3.3% year over year.
Quarterly results benefited from an increase in trading volumes. Average daily volume increased in four of its six asset classes.
CME Group’s revenues of $1.5 billion increased 3.2% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 0.7% year over year), market data and information services (up 5.8% year over year) and other (37% year over year). The top line beat the Zacks Consensus Estimate by 0.8%.
Total expenses inched up 0.07% year over year to $528.3 million, attributable to higher technology, compensation and benefits, as well as licensing and other fee agreements. It exceeded our estimate of $468.1 million.
Operating income increased 5% from the prior-year quarter to $959.6 million but missed our estimate of $995.2 million.
Average daily volume (ADV) was 26.4 million contracts, which decreased 1.9% year over year. Non-U.S. ADV reached 7.4 million contracts. The total average rate per contract was 69.5 cents.
Financial Update
As of Mar 31, 2024, CME Group had $1.5 billion of cash and marketable securities, down 48.5% from the 2023-end level. As of Mar 31, 2024, long-term debt was $2.6 billion, down 21.8% from 2023-end.
As of Mar 31, 2024, CME had shareholders' equity worth $27.1 billion, up 1.5% from the end of 2023.
Capital Deployment
CME Group paid out $2.3 billion in dividends, taking the payout to $24.8 billion since the implementation of the variable dividend policy in early 2012.
Nasdaq, Inc. (NDAQ - Free Report) is set to report first-quarter 2024 results on Apr 25, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at 65 cents, suggesting a decline of 5.8% from the year-ago quarter’s reported figure.
NDAQ’s earnings beat estimates in each of the last four quarters.
Cboe Global Markets, Inc. (CBOE - Free Report) is slated to report first-quarter 2024 results on May 3, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $2.04, suggesting an increase of 7.3% from the year-ago quarter’s reported figure.
CBOE’s earnings beat estimates in each of the last four quarters.
MarketAxess Holdings Inc. (MKTX - Free Report) is set to report first-quarter 2024 results on May 7, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $1.85, suggesting a decrease of 5.6% from the year-ago quarter’s reported figure.
MKTX’s earnings beat estimates in three of the last four quarters while missing in one.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CME Group (CME) Q1 Earnings Top Estimates, Revenues Rise Y/Y
CME Group Inc. (CME - Free Report) reported first-quarter 2024 adjusted earnings per share of $2.50, which beat the Zacks Consensus Estimate by 2.4%. The bottom line increased 3.3% year over year.
Quarterly results benefited from an increase in trading volumes. Average daily volume increased in four of its six asset classes.
CME Group Inc. Price, Consensus and EPS Surprise
CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote
Performance in Detail
CME Group’s revenues of $1.5 billion increased 3.2% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 0.7% year over year), market data and information services (up 5.8% year over year) and other (37% year over year). The top line beat the Zacks Consensus Estimate by 0.8%.
Total expenses inched up 0.07% year over year to $528.3 million, attributable to higher technology, compensation and benefits, as well as licensing and other fee agreements. It exceeded our estimate of $468.1 million.
Operating income increased 5% from the prior-year quarter to $959.6 million but missed our estimate of $995.2 million.
Average daily volume (ADV) was 26.4 million contracts, which decreased 1.9% year over year. Non-U.S. ADV reached 7.4 million contracts.
The total average rate per contract was 69.5 cents.
Financial Update
As of Mar 31, 2024, CME Group had $1.5 billion of cash and marketable securities, down 48.5% from the 2023-end level. As of Mar 31, 2024, long-term debt was $2.6 billion, down 21.8% from 2023-end.
As of Mar 31, 2024, CME had shareholders' equity worth $27.1 billion, up 1.5% from the end of 2023.
Capital Deployment
CME Group paid out $2.3 billion in dividends, taking the payout to $24.8 billion since the implementation of the variable dividend policy in early 2012.
Zacks Rank
CME currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Upcoming Releases
Nasdaq, Inc. (NDAQ - Free Report) is set to report first-quarter 2024 results on Apr 25, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at 65 cents, suggesting a decline of 5.8% from the year-ago quarter’s reported figure.
NDAQ’s earnings beat estimates in each of the last four quarters.
Cboe Global Markets, Inc. (CBOE - Free Report) is slated to report first-quarter 2024 results on May 3, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $2.04, suggesting an increase of 7.3% from the year-ago quarter’s reported figure.
CBOE’s earnings beat estimates in each of the last four quarters.
MarketAxess Holdings Inc. (MKTX - Free Report) is set to report first-quarter 2024 results on May 7, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $1.85, suggesting a decrease of 5.6% from the year-ago quarter’s reported figure.
MKTX’s earnings beat estimates in three of the last four quarters while missing in one.